Filing Details
- Accession Number:
- 0001203311-14-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-21 19:44:44
- Reporting Period:
- 2014-01-16
- Filing Date:
- 2014-01-21
- Accepted Time:
- 2014-01-21 19:44:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1588467 | G Jonathan Drachman | 21823 30Th Drive Se Bothell WA 98021 | Cmo & Evp, R & D | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-01-16 | 1,201 | $45.75 | 49,911 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Drachman on September 16, 2013.
- Amount of securities beneficially owned following reported transactions includes 48,500 Restricted Stock Units subject to vesting.